Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$191.51 - $216.16 $10 Million - $11.3 Million
52,376 Added 5.87%
944,852 $200 Million
Q2 2023

Aug 11, 2023

SELL
$187.64 - $206.25 $2.03 Million - $2.23 Million
-10,835 Reduced 1.2%
892,476 $172 Million
Q1 2023

May 15, 2023

BUY
$127.59 - $203.08 $1.67 Million - $2.66 Million
13,088 Added 1.47%
903,311 $183 Million
Q4 2022

Feb 13, 2023

BUY
$117.37 - $139.17 $2 Million - $2.37 Million
17,061 Added 1.95%
890,223 $114 Million
Q3 2022

Nov 14, 2022

SELL
$135.27 - $180.11 $3.98 Million - $5.3 Million
-29,429 Reduced 3.26%
873,162 $119 Million
Q2 2022

Aug 12, 2022

SELL
$108.81 - $179.33 $6.69 Million - $11 Million
-61,529 Reduced 6.38%
902,591 $160 Million
Q1 2022

May 13, 2022

BUY
$119.61 - $157.85 $1.32 Million - $1.74 Million
11,036 Added 1.16%
964,120 $139 Million
Q4 2021

Feb 08, 2022

SELL
$142.57 - $190.86 $635,149 - $850,281
-4,455 Reduced 0.47%
953,084 $147 Million
Q3 2021

Nov 15, 2021

BUY
$142.45 - $169.82 $10.9 Million - $13 Million
76,542 Added 8.69%
957,539 $163 Million
Q2 2021

Aug 13, 2021

BUY
$135.08 - $161.1 $2.99 Million - $3.57 Million
22,169 Added 2.58%
880,997 $139 Million
Q1 2021

May 12, 2021

BUY
$137.51 - $190.8 $1.44 Million - $2 Million
10,501 Added 1.24%
858,828 $119 Million
Q4 2020

Feb 11, 2021

BUY
$164.63 - $211.93 $140 Million - $180 Million
848,327 New
848,327 $149 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.